Assessing burden of central line–associated bloodstream infections present on hospital admission

Abstract

Few data exist on the incidence of central line-associated bloodstream infection present on hospital admission (CLABSI-POA), although the practice of patients maintaining central lines outside of hospitals is increasing. We describe patients presenting to an academic medical center with CLABSI-POA over 1 year. Of the 130 admissions, half presented from home infusion (47%), followed by oncology clinic (22%), hemodialysis (14%), and skilled nursing facility (8%). Efforts to reduce CLABSIs should address patients across the entire health care system.

Occurrence rate and risk factors for long‐term central line‐associated bloodstream infections in patients with cancer: A systematic review

“…Central line-associated bloodstream infection (CLABSI) is a public health problem and one of the major challenges for healthcare systems (Baier et al, 2020;Leeman et al, 2020;Stevens et al, 2014).…”

“…Central line‐associated bloodstream infection (CLABSI) is a public health problem and one of the major challenges for healthcare systems (Baier et al, 2020; Leeman et al, 2020; Stevens et al, 2014). According to the Centers for Disease Control and Prevention (CDC) definition, a CLABSI is a laboratory‐confirmed bloodstream infection not related to another site of infection that occurs within 48 h of a central line placement (CDC & National Healthcare Safety Network, 2021).…”